Acute Myeloid Leukemia
Research from University of Texas provides new data about acute myeloid leukemia
Published in Hematology Week, March 24th, 2008
"Serum 132 microglobulin (beta 2M) is prognostic in other hematologic malignancies; therefore, we evaluated its prognostic significance in acute myeloid leukemia (AML). Multivariate analyses were used to examine the effect of pretreatment serum beta 2M levels on clinical outcomes in patients with AML. beta 2M was associated with poorer survival in older but not younger patients," scientists writing in the journal Clinical Cancer Research report.
"We thus fit separate Cox survival models in patients above and below age 60 years treated with remission induction therapy containing high-dose cytarabine (n = 1,280). In each age group, 50% of the patients were used to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2008-03-24)
More Articles from Hematology Week
- Lymphoma
USC researchers find benefit for lymphoma patients in combined PET-CT scanning - Obesity and Diabetes
Monthly personal counseling helps maintain weight loss - Osteosarcoma
Same process discovered to both form skeleton and protect it for life - Acute Myelogenous Leukemia
Study results from University of Massachusetts provide new insights into acute myelogenous leukemia - Alpha-thalassemia
Research data from National University update understanding of alpha-thalassemia - Congestive Heart Failure
Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study With PL-3994 for the Treatment of Congestive Heart Failure - More from this issue of Hematology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
